InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Browse the full record of transactions filed by Markels John, 董事. Officer active across 2 companies, notably Sangamo Therapeutics, INC. Cumulatively, 6 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €23k. History available since 25 February 2022. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Markels John is Administrateur and serves as a director at Sangamo Therapeutics, INC and Arcturus Therapeutics Holdings Inc. He has 6 filings in total. Across the 6 most recent filings available, the period runs from 2022-03-01 to 2025-06-16, with buys of EUR 23280 and sells of EUR 0, and the modal transaction nature is Attribution.